查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2012035

生物种子处理市场：依微生物类型、应用方法、製剂形式、作物类型和销售管道划分－2026-2032年全球市场预测

Biological Seed Treatment Market by Microbial Type, Application Method, Formulation, Crop Type, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，生物种子处理市场价值将达到 17.1 亿美元，到 2026 年将成长到 19.4 亿美元，到 2032 年将达到 45.9 亿美元，年复合成长率为 15.17%。

主要市场统计数据
基准年 2025 17.1亿美元
预计年份：2026年 19.4亿美元
预测年份 2032 45.9亿美元
复合年增长率 (%) 15.17%

生物种子处理简述：说明影响生物种子处理技术应用和创新的技术交会点、生产者动机和营运重点。

生物种子处理领域融合了农业、微生物学和永续农业，为提高种子性能和促进作物早期生长提供了广泛的解决方案，同时减少了对合成材料的依赖。微生物製剂、递送技术和监管核准的创新正迅速吸引种子企业、农药生产商和种植者的关注，他们都在寻求兼顾生产力和环境保护。

关键且相互整合的技术、监管和商业性变革正在重塑生物种子处理领域的创新路径和竞争优势。

在技​​术进步、监管改革和价值链重组的推动下，生物种子处理领域正经历着一场决定性的变革。在研发方面，更快速的菌株发现工具、高通量筛检以及製剂科学的进步，使得多种微生物得以商业化，并提高了其保质期和种子附着力。同时，与数位农业和数据驱动决策支援的融合，正将生物製品与精准播种和变数施肥技术相结合，为种植者创造更具针对性的价值提案。

2025 年美国关税政策将如何重塑整个生物种子加工价值链的供应链、筹资策略和跨国合作。

美国2025年实施的关税政策调整对生物种子处理生态系统产生了复杂的影响，波及原料采购、成分流动和跨国合作。由于许多高效微生物菌株、载体材料和特殊添加剂都存在于复杂的国际供应链中，对某些进口原材料征收的关税改变了成本结构，迫使生产商和配方商即时调整营运。

基于细分市场的洞察揭示了微生物种类、应用方法、配方、作物特异性和销售管道如何决定产品和商业策略。

透过市场区隔所获得的洞察，为产品开发人员和市场推广团队提供了清晰的技术和商业性路径。微生物的类型至关重要。细菌菌株通常具有特定的促生长、抑病或营养活化功能，而真菌菌株则提供不同的作用机制，例如菌根共生和拮抗活性。了解这些作用机制、稳定性和适用性的差异，对于配方选择和目标作物策略都大有裨益。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和业务重点可作为市场进入和业务扩大策略的指南。

区域趋势塑造了生物种子处理领域的机会和实施重点。在美洲，成熟的农业供应链和大规模的行栽作物种植系统催生了对可扩展、倡议种子处理的需求，这些需求需与病虫害综合防治方案和零售商管理计划相契合。同时，田间示范和与经销商建立牢固的关係对于大规模商业农场的推广应用仍然至关重要。

主要企业如何将药物发现、製剂工程和商业性执行结合，从而在生物种子处理领域建立可持续的竞争优势？

该领域的主要企业正透过整合涵盖微生物发现、製剂工程、种子处理适用性测试和销售管道执行等多学科能力来建立其竞争优势。技术提供者、种子企业和特种製剂生产商之间的策略合作伙伴关係，能够将有前景的实验室成果快速转化为实际的农场应用，同时分担研发和註册过程中涉及的资金和监管负担。

为高阶主管提供可操作的、高优先级的行动方案，以加速采用生物种子处理技术，增强供应韧性，并协调监管和商业策略。

产业领导者应优先考虑能够加速产品市场契合度、同时确保供应链韧性和合规性的整合策略。首先，应投资于能够解决种子品系相容性、储存稳定性和易用性问题的配方平台，从而减轻种子加工商和经销商的负担。同时，应投入资源进行强有力的田间检验项目，以在具有代表性的地区和种植系统中产生可重复的农业化学品证据。

概述透明的调查方法，描述资料来源、相关人员参与和分析技术，以产生对生物种子处理的实用见解。

本研究整合了一手和二手资料，建构了产品、监管、区域和竞争趋势的全面图像。一手资料包括对研发经理、种子技术专家、监管专家和销售管道伙伴的结构化访谈，并辅以田间农业回馈，以实际结果佐证技术主张。二手资料涵盖同行评审文献、监管指导文件、行业协会公告和公开的企业资讯披露，从而对趋势进行多角度分析并检验相关主张。

一个全面的结论强调科学机会、商业性纪律和供应链韧性，以此作为扩大生物种子处理的蓝图。

生物种子处理领域日新月异，既蕴含丰富的科学机会，也面临复杂的商业性挑战。微生物技术的发现和配方科学的进步为产品性能的提升铺平了道路，但不断变化的法规、供应链以及生产商的期望，正迫使我们重新定义产品的研发和交付方式。在这种环境下取得成功，需要一种平衡的策略，将卓越的技术、严谨的营运和敏锐的市场洞察力融为一体。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：按微生物类型分類的生物种子处理市场

  • 细菌
  • 真菌

第九章：生物种子处理的市场应用方法

  • 种子披衣
    • 覆盖
    • 薄膜涂层
  • 种子拌药
  • 种子製粒

第十章：依配方分類的生物种子处理市场

  • 颗粒
  • 液体
    • 油腻的
    • 水溶液
  • 粉末

第十一章：生物种子处理市场：依作物类型划分

  • 粮食
    • 玉米
    • 米
    • 小麦
  • 水果和蔬菜
  • 油籽/豆类
    • 油菜籽
    • 大豆
    • 向日葵

第十二章：生物种子加工市场：依销售管道划分

  • 离线
  • 在线的

第十三章：生物种子处理市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：生物种子处理市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：生物种子处理市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国生物种子处理市场

第十七章：中国生物种子加工市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agrinos AS
  • AMVAC Chemical Corporation
  • BASF SE
  • Bayer AG
  • Bioworks Inc
  • Certis USA LLC
  • Corteva Agriscience
  • East-West Seed
  • FMC Corporation
  • Germains Seed Technology
  • Groupe Limagrain SA
  • Incotec Group BV
  • Italpollina SpA
  • Koppert Biological Systems
  • Marrone Bio Innovations Inc
  • Novozymes A/S
  • Nufarm Limited
  • Plant Health Care plc
  • Rizobacter Argentina SA
  • SAKATA SEED CORPORATION
  • Sumitomo Chemical Co Ltd
  • Syngenta AG
  • UPL Limited
  • Valent BioSciences LLC
  • Verdesian Life Sciences LLC
Product Code: MRR-43539E5D2D2B

The Biological Seed Treatment Market was valued at USD 1.71 billion in 2025 and is projected to grow to USD 1.94 billion in 2026, with a CAGR of 15.17%, reaching USD 4.59 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.71 billion
Estimated Year [2026] USD 1.94 billion
Forecast Year [2032] USD 4.59 billion
CAGR (%) 15.17%

A concise orientation to biological seed treatments explaining technological intersections, grower drivers, and operational priorities shaping adoption and innovation

The biological seed treatment sector sits at the intersection of agronomy, microbiology, and sustainable agriculture, offering a range of solutions that enhance seed performance and early crop vigor while reducing reliance on synthetic inputs. Innovations in microbial formulations, delivery technologies, and regulatory acceptance have accelerated interest from seed companies, agrochemical firms, and growers aiming to balance productivity with environmental stewardship.

This introduction frames the strategic importance of biological seed treatments by outlining core drivers and operational realities shaping adoption. It highlights how increasing emphasis on soil health, integrated pest management, and stewardship programs is elevating the role of seed-applied biologicals as part of broader crop protection and nutrition packages. The narrative further explains how evolving production practices and farm-level decision criteria are redefining product development priorities, creating new technical demands around compatibility with seed treatments, storage stability, and application efficacy.

Finally, this section establishes the analytical approach used throughout the document by connecting technological trends, regulatory influences, and commercial dynamics to practical implications for stakeholders. It sets the stage for subsequent sections that examine landscape shifts, policy impacts, segmentation nuances, regional dynamics, competitive positioning, and actionable recommendations for leaders seeking to translate scientific promise into commercial success.

Critical and converging technological, regulatory, and commercial shifts that are reshaping innovation pathways and competitive advantage in biological seed treatments

The landscape for biological seed treatments is undergoing decisive shifts driven by technological advances, regulatory recalibrations, and reconfigured value chains. Across research and development, accelerated strain discovery tools, high-throughput screening, and improved formulation science are enabling diverse microorganisms to be productized with enhanced shelf life and seed adherence. At the same time, integration with digital agronomy and data-driven decision support is aligning biological offerings with precision sowing and variable-rate practices, creating a more targeted value proposition for growers.

Regulatory frameworks are increasingly recognizing the distinct risk profiles of biologicals relative to synthetic chemistries, prompting more nuanced registration pathways and localized approval processes. This trend supports market entry for novel strains but also raises the bar for standardized testing, product characterization, and post-launch stewardship. Alongside these governance changes, commercial models are evolving; partnerships between seed companies, formulation specialists, and distributors are becoming more collaborative, reflecting the need to bundle biologicals with other seed technologies and services.

Furthermore, supply chain resilience and sourcing strategies are being revisited as manufacturers prioritize localized production and redundancy to mitigate logistics disruptions. Consumer expectations and retailer sustainability commitments are also pressuring the industry to demonstrate measurable environmental outcomes, reinforcing the need for robust field validation and transparent communication. Collectively, these transformative shifts are recalibrating competitive advantage toward players who can combine scientific credibility, commercialization agility, and demonstrable on-farm benefits.

How 2025 United States tariff policies are reshaping supply chains, sourcing strategies, and cross-border collaboration across the biological seed treatment value chain

Policy changes enacted in 2025 regarding tariffs in the United States have introduced complex ramifications for the biological seed treatment ecosystem, affecting raw material sourcing, component movement, and cross-border collaborations. Because many active microbial strains, carrier materials, and specialized excipients are part of intricate international supply chains, duties applied to certain imported inputs have altered cost structures and prompted immediate operational adjustments among manufacturers and formulators.

This tariff environment has incentivized relocation of certain production steps closer to end markets, with firms reassessing the distribution of fermentation, formulation, and packaging activities. As a consequence, procurement teams are placing greater emphasis on supplier qualification and domestic alternative sourcing to reduce exposure to trade-related price volatility. These shifts are also prompting contract renegotiations and longer-term supplier agreements designed to secure throughput and maintain product continuity for seed companies and their channel partners.

In addition, the tariffs have had indirect effects on collaborative R&D and knowledge exchange. Cross-border academic-industry projects and contract research organizations face higher transactional friction when materials and prototypes move across borders, encouraging stakeholders to increase local capacity for early-stage development and testing. Meanwhile, distributors and seed companies are adapting commercialization timelines and inventory strategies to ensure availability at sowing windows, prioritizing supplier diversity and logistical redundancy. Therefore, the cumulative impact of the 2025 tariff measures is accelerating structural reconfiguration across the value chain, compelling industry participants to invest in localized capabilities, strategic sourcing, and risk mitigation to preserve market continuity and meet grower needs.

Segmentation-driven insights revealing how microbial type, application method, formulation, crop specificity, and sales channels determine product and commercial strategy

Insights derived from segmentation reveal distinct technical and commercial pathways that product developers and go-to-market teams must navigate. Microbial type matters: bacterial strains often deliver specific growth-promoting, disease-suppressive, or nutrient-mobilizing functions, while fungal strains provide alternative modes of action including mycorrhizal associations and antagonist behavior. Recognizing differences in mode of action, stability, and compatibility informs both formulation choices and target-crop strategies.

Application method differentiates both product design and field performance. Seed coating approaches prioritize uniform coverage and adhesion, with encrusting enabling high-load applications and film coating delivering thin, uniform layers that facilitate mechanical seed handling. Seed dressing provides a balance between ease of application and protective benefits during storage and sowing, whereas seed pelleting modifies seed geometry for small-seeded crops or precision sowing systems. Each method imposes constraints on formulation viscosity, particle size, and carrier selection, shaping development priorities.

Formulation format drives shelf life, distribution logistics, and end-user handling. Granular formats can offer physical robustness for certain deployment systems, liquids afford ease of mixing and rapid seed surface interaction with oil-based variants enhancing adherence and water-based variants improving dispersibility, while powders remain attractive where drying stability and lightweight transport are important. The choice among granule, liquid, and powder at development stage directly affects production investments and compatibility with seed treatment lines.

Crop type determines commercial focus and performance targets. Cereals such as corn, rice, and wheat present high-volume platforms where seed treatments must be compatible with established seed production and agronomic practices. Fruits and vegetables demand formulations that accentuate early vigor and transplant success, whereas oilseeds and pulses including rapeseed, soybean, and sunflower require solutions tailored to seed size, handling, and disease pressures. Sales channel considerations also influence go-to-market strategy: offline channels remain dominant for relationship-driven sales, while online channels are emerging as efficient means to reach specialty growers and remote markets. Synthesizing these segmentation dimensions provides a nuanced map for prioritizing product pipelines, tailoring registrational strategies, and designing commercial models that reflect crop- and channel-specific requirements.

Regional dynamics and operational priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific that inform market entry and scaling strategies

Regional dynamics shape opportunity contours and executional priorities across the biological seed treatment landscape. In the Americas, established agricultural supply chains and large-scale row-crop systems create demand for scalable, mechanization-compatible seed treatments that align with integrated pest management programs and retailer stewardship initiatives. Meanwhile, field validation and strong distributor relationships remain pivotal for adoption in large commercial operations.

Europe, Middle East & Africa present a heterogeneous mix of regulatory environments and cropping systems that favor localized product adaptation and robust environmental safety data. In many parts of this region, policy drivers and retailer sustainability commitments accelerate interest in low-residue and biologically based inputs, making regulatory navigation and evidence of ecological benefit essential prerequisites for commercial success.

Asia-Pacific is characterized by diverse farm sizes, crop mixes, and rapidly evolving input retail models, with smallholder prevalence in some markets and high-intensity commercial agriculture in others. This heterogeneity necessitates differentiated packaging, dosing, and application methods, as well as flexible distribution strategies that can address both institutional buyers and fragmented retail networks. Across all regions, regional infrastructure, local manufacturing capacity, and regulatory clarity remain decisive factors informing where companies elect to invest in production and field demonstration activities.

How leading firms are combining discovery, formulation engineering, and commercial execution to establish durable competitive advantages in biological seed treatments

Leading companies in the space are building advantage by integrating multidisciplinary capabilities that span microbial discovery, formulation engineering, seed treatment compatibility testing, and channel execution. Strategic collaborations between technology providers, seed companies, and specialty formulators are enabling faster translation from lab-scale promise to on-farm performance, while also sharing the capital and regulatory burden associated with development and registration.

Competitive differentiation is being achieved through deep investments in proprietary strain libraries, formulation platforms that enhance survivability and adherence on seed surfaces, and tailored service offerings such as agronomic support and stewardship programs. Firms that combine technical credibility with robust field-validation protocols are better positioned to secure distribution agreements and channel trust. Additionally, upstream investments in manufacturing flexibility and redundant supply capabilities help companies mitigate trade-related risks and maintain supply continuity during peak sowing windows.

Finally, customer-centric approaches that incorporate grower trials, localized technical support, and clear messaging around compatibility with existing seed treatment chemistries are proving essential for adoption. Companies that demonstrate measurable agronomic benefit and operational ease of use will likely sustain stronger relationships with seed processors, distributors, and end-users.

Practical and prioritized actions for executives to accelerate adoption, strengthen supply resilience, and align regulatory and commercial strategies for biological seed treatments

Industry leaders should prioritize an integrated strategy that accelerates product-market fit while safeguarding supply chain resilience and regulatory compliance. First, invest in formulation platforms that address seed-line compatibility, storage stability, and application ergonomics to reduce friction for seed processors and distributors. Concurrently, allocate resources to robust field validation programs that generate reproducible agronomic evidence across representative geographies and cropping systems.

Second, diversify sourcing and manufacturing footprints to mitigate trade-related disruptions and provide faster response to regional demand shifts. This includes developing localized fermentation and formulation capabilities where feasible, as well as qualifying multiple suppliers for critical excipients and carriers. Third, pursue strategic partnerships that blend proprietary microbial assets with established seed treatment infrastructure, enabling faster scale-up and shared commercial risk.

Fourth, align commercial models with channel needs by offering tailored packaging, dose formats, and technical services that support both offline distributor networks and emerging online procurement channels. Fifth, engage proactively with regulatory authorities and participate in harmonization efforts to shape practical, science-based registration pathways. Lastly, strengthen value communication through transparent performance data, environmental benefit narratives, and clear stewardship guidelines to build trust across growers, retailers, and policymakers.

A transparent methodological overview describing data sources, stakeholder engagements, and analytical approaches employed to produce actionable biological seed treatment insights

This research synthesized primary and secondary intelligence to develop a comprehensive view of product, regulatory, regional, and competitive dynamics. Primary inputs included structured interviews with R&D leaders, seed technologists, regulatory specialists, and channel partners, supplemented by field-level agronomic feedback to ground technical claims in practical outcomes. Secondary inputs encompassed peer-reviewed literature, regulatory guidance documents, trade association communications, and publicly available company disclosures to triangulate trends and validate assertions.

Analytical methods combined qualitative thematic analysis with comparative evaluation of formulation platforms and application methods. Segmentation mapping was employed to connect microbial characteristics with formulation choices, application constraints, and crop-specific needs. Regional analysis integrated policy review, supply chain assessment, and go-to-market considerations to highlight differential requirements across geographies. Attention was given to ensuring that conclusions reflect operational realities and stakeholder perspectives rather than relying solely on theoretical performance metrics.

Where possible, findings were cross-checked with multiple independent sources and iterated through follow-up discussions to refine interpretations. Limitations were acknowledged, including variability in on-farm performance due to environmental heterogeneity and differences in seed production practices. These methodological choices were selected to deliver actionable intelligence that balances scientific rigor with commercial relevance.

An integrated conclusion emphasizing scientific opportunity, commercial discipline, and supply chain resilience as the blueprint for scaling biological seed treatments

The evolving biological seed treatment landscape presents a compelling combination of scientific opportunity and commercial complexity. Advances in microbial discovery and formulation science are unlocking new performance pathways, while shifts in regulation, supply chains, and grower expectations are redefining how products must be developed and delivered. Success in this environment requires a balanced approach that pairs technical excellence with operational discipline and market-savvy execution.

Stakeholders who excel will be those that can translate microbial potential into robust, user-friendly products supported by rigorous field evidence and resilient supply chains. They will also engage proactively with regulators and channel partners to streamline adoption and build confidence among end-users. In short, the path to sustainable, scaled impact lies in integrating discovery, formulation, validation, and commercialization into a cohesive strategy that anticipates regional nuances and adapts to policy shifts.

This conclusion underscores a pragmatic mandate for the industry: continue investing in science, but do so in tandem with pragmatic supply chain planning and clear commercial propositions that address the everyday priorities of seed processors, distributors, and growers.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Seed Treatment Market, by Microbial Type

  • 8.1. Bacteria
  • 8.2. Fungi

9. Biological Seed Treatment Market, by Application Method

  • 9.1. Seed Coating
    • 9.1.1. Encrusting
    • 9.1.2. Film Coating
  • 9.2. Seed Dressing
  • 9.3. Seed Pelleting

10. Biological Seed Treatment Market, by Formulation

  • 10.1. Granule
  • 10.2. Liquid
    • 10.2.1. Oil Based
    • 10.2.2. Water Based
  • 10.3. Powder

11. Biological Seed Treatment Market, by Crop Type

  • 11.1. Cereals
    • 11.1.1. Corn
    • 11.1.2. Rice
    • 11.1.3. Wheat
  • 11.2. Fruits & Vegetables
  • 11.3. Oilseeds & Pulses
    • 11.3.1. Rapeseed
    • 11.3.2. Soybean
    • 11.3.3. Sunflower

12. Biological Seed Treatment Market, by Sales Channel

  • 12.1. Offline
  • 12.2. Online

13. Biological Seed Treatment Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Biological Seed Treatment Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Biological Seed Treatment Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Biological Seed Treatment Market

17. China Biological Seed Treatment Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agrinos AS
  • 18.6. AMVAC Chemical Corporation
  • 18.7. BASF SE
  • 18.8. Bayer AG
  • 18.9. Bioworks Inc
  • 18.10. Certis USA LLC
  • 18.11. Corteva Agriscience
  • 18.12. East-West Seed
  • 18.13. FMC Corporation
  • 18.14. Germains Seed Technology
  • 18.15. Groupe Limagrain SA
  • 18.16. Incotec Group BV
  • 18.17. Italpollina SpA
  • 18.18. Koppert Biological Systems
  • 18.19. Marrone Bio Innovations Inc
  • 18.20. Novozymes A/S
  • 18.21. Nufarm Limited
  • 18.22. Plant Health Care plc
  • 18.23. Rizobacter Argentina S.A.
  • 18.24. SAKATA SEED CORPORATION
  • 18.25. Sumitomo Chemical Co Ltd
  • 18.26. Syngenta AG
  • 18.27. UPL Limited
  • 18.28. Valent BioSciences LLC
  • 18.29. Verdesian Life Sciences LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOLOGICAL SEED TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FUNGI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FUNGI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FUNGI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY ENCRUSTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY ENCRUSTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY ENCRUSTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FILM COATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FILM COATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FILM COATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED DRESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED DRESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED DRESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED PELLETING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED PELLETING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED PELLETING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OIL BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OIL BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OIL BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY WATER BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY WATER BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY WATER BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CORN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CORN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CORN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY RICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY RICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY RICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY WHEAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY WHEAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY WHEAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY RAPESEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY RAPESEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY RAPESEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SOYBEAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SOYBEAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SOYBEAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SUNFLOWER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SUNFLOWER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SUNFLOWER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 175. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 176. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 177. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 178. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 180. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 181. GCC BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 205. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 206. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 207. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 208. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 210. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 211. G7 BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 215. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 216. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 217. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 218. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 220. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 221. NATO BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL BIOLOGICAL SEED TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY MICROBIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY APPLICATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SEED COATING, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CROP TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY CEREALS, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY OILSEEDS & PULSES, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA BIOLOGICAL SEED TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)